OPGN

OpGen Inc. (OPGN) | Rumor.io

OpGen

OPGN

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)5.2M

Net income (annual)12M

Social

What share of all stock conversation is about OPGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Apr 20

OPGN's stock price may appear as zero or a few cents due to a lack of public price quotes, but the actual trading price is $23.
The company's decision to transition and acquire iCapX Sdn. Bhd. has led to complex accounting delays, with a focus on accurately valuing intangible fintech assets.
OPGN's stock may rebound to $23.00 or higher due to the company's 75% ownership stake and the potential for a favorable SEC ruling, allowing it to list on the Pink Sheets.

Generated by AI

Sentiment

Of the messages about OPGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.73% +20.85
Bearish	—	—	—	5.27% -20.85

Bullish· Apr 8

The float of $OPGN is low at 10M shares, which could lead to a significant price increase if the company makes progress.
The CEO has recently bought more shares at a price of $1, indicating confidence in the company's future.
Technical analysis suggests $OPGN is forming a rounded bottom and may run to the $1.50 area, with limited resistance above $1.42.

Bearish· May 20

The company's stock price may be driven down due to its small float and potential dilution.
The company's history of reverse stock splits and significant share price drops may indicate a lack of investor confidence.
The company's financials may be unsustainable, as investors who held the stock since its IPO in 2015 would need the price to increase to $500,000 per share to breakeven.

Generated by AI

Topics

Of the messages about OPGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	17.01%
Announcements	—	—	—	65.63%
Controversies	—	—	—	4.86%
Earnings	—	—	—	0%
Macro	—	—	—	11.81%
Technical Analysis	—	—	—	0.69%

Earnings· Aug 1

Analysts expected OpGen, Inc. to report earnings per share (EPS) around -$0.15, but the company may beat estimates with strong sales from South America.
The company's South America sales are a key factor in its earnings report, and investors are hoping for a big beat on EPS.
OpGen, Inc.'s earnings report is closely watched, and a strong performance could have a positive impact on the company's stock price.

Announcements· Oct 13

OpGen, Inc. (OPGN) received a $15 million payment from the exercise of warrants, which will help fund the company's operations and repay a loan.
The company has entered into a Preferred Stock Purchase Agreement with an investor to acquire 1,000 shares at $1,000 each, with gross proceeds of $1 million.
OpGen has also received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems to a strategic partner, which will be used to fund the company's operations while it pursues a potential strategic transaction.

Technical Analysis· Mar 26

The shorts have finished playing, and the buyers are regaining control on the 15-minute chart, indicating a potential move forward.
A rebound on the former supply zone is possible, and the price is currently consolidating, forming a nice base with a potential trade idea at $0.70.
The price has broken above the downtrend line and $0.83, creating a room for a potential move to $0.98 and then $1.22.

Generated by AI

Community

Of the messages about OPGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	91.36%
Newcomers	—	—	0%	8.64%

Regulars· Mar 13

The regulars are focused on the low trading volume and its potential impact on the stock's performance, with some speculating that it could lead to a reversal in the stock's price.
The relisting of the stock is a major topic of discussion, with some participants highlighting the importance of the 10-K filing and the need for better communication from the company's CEO to boost investor confidence.
The stock's price action is being closely watched, with some participants noting that the stock's performance is not yet out of the woods, and that a break above $35 could lead to a wave of selling.

Newcomers· Mar 27

Some users believe OpGen, Inc. will follow a similar pattern as another company, Minm, which announced a merger, and predict a merger situation is in the works for OpGen.
The stock is expected to break through certain price levels, such as $0.73 and $1, with some users anticipating a potential pop or significant price increase.
Users are watching for a potential earnings release or update on OpGen's website, with one user speculating that either the release will occur or the website will be updated on March 27th.

Generated by AI

Also Discussed

Investors talking about OPGN also mention

#	Name	Attention
1	YTEN - Yield10 Bioscience, Inc.	——
2	Xenetic Biosciences, Inc.XBIO	0%new
3	Euroseas Ltd.ESEA	0%0
4	Nanoviricides Inc.NNVC	0%0
5	Xtant Medical Holdings Inc.XTNT	0%0
6	Globus Maritime Limited Common StockGLBS	0%new
7	Precipio Inc.PRPO	0%0
8	Arcadia Biosciences Inc.RKDA	0.01%0
9	Moleculin Biotech, Inc.MBRX	0%0
10	Top Ships Inc.TOPS	0%+0

OpGen Inc.

Financial Services
Capital Markets

OpGen Inc. is a biotechnology company that focuses on developing molecular diagnostics and bioinformatics solutions aimed at combating infectious diseases. The company's core purpose is to provide innovative diagnostic products and services that enable rapid identification and treatment guidance for a variety of pathogens. OpGen Inc. leverages advanced technology platforms such as Acuitas AMR Gene Panel, which aids in detecting antimicrobial resistance genes, and Unyvero, a multiplex PCR-based diagnostic system. These solutions are pivotal in the healthcare sector, assisting clinical laboratories, hospital networks, and health systems worldwide in improving patient outcomes through timely and precise diagnostics. Based in Gaithersburg, Maryland, OpGen Inc. plays a vital role in the medical and healthcare markets, addressing rising concerns over antibiotic resistance and infection management, by equipping healthcare professionals with reliable diagnostic tools. Its contributions are crucial in advancing the fields of preventive care and infectious disease control.

Website

Location

23219 Stringtown Road

Clarksburg, MD, 20871

United States

Social

What share of all stock conversation is about OPGN?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Apr 20

OPGN's stock price may appear as zero or a few cents due to a lack of public price quotes, but the actual trading price is $23.
The company's decision to transition and acquire iCapX Sdn. Bhd. has led to complex accounting delays, with a focus on accurately valuing intangible fintech assets.
OPGN's stock may rebound to $23.00 or higher due to the company's 75% ownership stake and the potential for a favorable SEC ruling, allowing it to list on the Pink Sheets.

Generated by AI

Sentiment

Of the messages about OPGN that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	94.73% +20.85
Bearish	—	—	—	5.27% -20.85

Bullish· Apr 8

The float of $OPGN is low at 10M shares, which could lead to a significant price increase if the company makes progress.
The CEO has recently bought more shares at a price of $1, indicating confidence in the company's future.
Technical analysis suggests $OPGN is forming a rounded bottom and may run to the $1.50 area, with limited resistance above $1.42.

Bearish· May 20

The company's stock price may be driven down due to its small float and potential dilution.
The company's history of reverse stock splits and significant share price drops may indicate a lack of investor confidence.
The company's financials may be unsustainable, as investors who held the stock since its IPO in 2015 would need the price to increase to $500,000 per share to breakeven.

Generated by AI

Topics

Of the messages about OPGN that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	17.01%
Announcements	—	—	—	65.63%
Controversies	—	—	—	4.86%
Earnings	—	—	—	0%
Macro	—	—	—	11.81%
Technical Analysis	—	—	—	0.69%

Earnings· Aug 1

Analysts expected OpGen, Inc. to report earnings per share (EPS) around -$0.15, but the company may beat estimates with strong sales from South America.
The company's South America sales are a key factor in its earnings report, and investors are hoping for a big beat on EPS.
OpGen, Inc.'s earnings report is closely watched, and a strong performance could have a positive impact on the company's stock price.

Announcements· Oct 13

OpGen, Inc. (OPGN) received a $15 million payment from the exercise of warrants, which will help fund the company's operations and repay a loan.
The company has entered into a Preferred Stock Purchase Agreement with an investor to acquire 1,000 shares at $1,000 each, with gross proceeds of $1 million.
OpGen has also received an advanced payment of €750,000 related to the sale of certain Unyvero A50 systems to a strategic partner, which will be used to fund the company's operations while it pursues a potential strategic transaction.

Technical Analysis· Mar 26

The shorts have finished playing, and the buyers are regaining control on the 15-minute chart, indicating a potential move forward.
A rebound on the former supply zone is possible, and the price is currently consolidating, forming a nice base with a potential trade idea at $0.70.
The price has broken above the downtrend line and $0.83, creating a room for a potential move to $0.98 and then $1.22.

Generated by AI

Community

Of the messages about OPGN, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	100%	91.36%
Newcomers	—	—	0%	8.64%

Regulars· Mar 13

The regulars are focused on the low trading volume and its potential impact on the stock's performance, with some speculating that it could lead to a reversal in the stock's price.
The relisting of the stock is a major topic of discussion, with some participants highlighting the importance of the 10-K filing and the need for better communication from the company's CEO to boost investor confidence.
The stock's price action is being closely watched, with some participants noting that the stock's performance is not yet out of the woods, and that a break above $35 could lead to a wave of selling.

Newcomers· Mar 27

Some users believe OpGen, Inc. will follow a similar pattern as another company, Minm, which announced a merger, and predict a merger situation is in the works for OpGen.
The stock is expected to break through certain price levels, such as $0.73 and $1, with some users anticipating a potential pop or significant price increase.
Users are watching for a potential earnings release or update on OpGen's website, with one user speculating that either the release will occur or the website will be updated on March 27th.

Generated by AI

OpGen

Social

Apr 20

Sentiment

Bullish· Apr 8

Bearish· May 20

Topics

Earnings· Aug 1

Announcements· Oct 13

Technical Analysis· Mar 26

Community

Regulars· Mar 13

Newcomers· Mar 27

Also Discussed

OpGen Inc.

Company Information

Location

Also Discussed

Social

Apr 20

Sentiment

Bullish· Apr 8

Bearish· May 20

Topics

Earnings· Aug 1

Announcements· Oct 13

Technical Analysis· Mar 26

Community

Regulars· Mar 13

Newcomers· Mar 27